SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas

Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma

Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638

Phaeochromocytoma

Lenders, J. W. M., Eisenhofer, G., Mannelli, M., & Pacák, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,541

Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087

Mutations in SDHC cause autosomal dominant paraganglioma, type 3

Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875

Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency

Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730

SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma

Hao, H.-X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.-P., Kunst, H., Devilee, P., Cremers, C. W. R. J., Schiffman, J. D., Bentz, B. G., et al. (2009) · Science · doi:10.1126/science.1175689 · Cited by 702

SDHA is a tumor suppressor gene causing paraganglioma

Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaı̂tre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 645

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F. B. M., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 554

SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

Bayley, J., Kunst, H. P. M., Cascón, A., Sampietro, M. L., Gaal, J., Korpershoek, E., Hinojar‐Gutiérrez, A., Timmers, H. J. L. M., Hoefsloot, L. H., Hermsen, M. A. J. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70007-3 · Cited by 283

Succinate dehydrogenase and fumarate reductase from Escherichia coli

Cecchini, G., Schröder, I., Gunsalus, R. P., & Maklashina, E. (2002) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00238-9 · Cited by 279

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline

Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827

SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways

Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M. M., Skinner, M. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.001 · Cited by 1,000

The emerging role and targetability of the TCA cycle in cancer metabolism

Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2017) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 586

Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

Favier, J., Amar, L., & Gimenez‐Roqueplo, A. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.188 · Cited by 484

Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas

Mete, Ö., Asa, S. L., Gill, A. J., Kimura, N., de Krijger, R. R., & Tischler, A. S. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09704-6 · Cited by 432

Oncometabolites: linking altered metabolism with cancer

Yang, M. H., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 441

Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas

Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine Related Cancer · doi:10.1530/erc-11-0170 · Cited by 356

Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma

Gill, A. J., Hes, O., Papathomas, T. G., Šedivcová, M., Tan, P. H., Agaimy, A., Andresen, P. A., Kedziora, A., Clarkson, A., Toon, C. W., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000292 · Cited by 348

New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification

Crona, J., Taïeb, D., & Pacák, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 330

Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas

The NGS in PPGL (NGSnPPGL) Study Group, Toledo, R. A., Burnichon, N., Cascón, A., Benn, D. E., Bayley, J., Welander, J., Tops, C. M. J., Firth, H. V., Dwight, T., et al. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.185 · Cited by 275

New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

Trpkov, K., Hes, O., Williamson, S. R., Adeniran, A., Agaimy, A., Alaghehbandan, R., Amin, M. B., Argani, P., Chen, Y., Liang Cheng, C., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00779-w · Cited by 275

Succinate dehydrogenase (SDH)‐deficient neoplasia

Gill, A. J. (2017) · Histopathology · doi:10.1111/his.13277 · Cited by 263

Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic Testing

Fishbein, L. M., Merrill, S. L., Fraker, D. L., Cohen, D. L., & Nathanson, K. L. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2942-5 · Cited by 242

SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)

Papathomas, T. G., Oudijk, L., Persu, A., Gill, A. J., van Nederveen, F. H., Tischler, A. S., Tissier, F., Volante, M., Matías‐Guiu, X., Smid, M., et al. (2015) · Modern Pathology · doi:10.1038/modpathol.2015.41 · Cited by 228

Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma

Williamson, S. R., Eble, J. N., Amin, M. B., Gupta, N., Smith, S. C., Sholl, L. M., Montironi, R., Hirsch, M. S., & Hornick, J. L. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.86 · Cited by 226

Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia

Gill, A. J. (2012) · Pathology · doi:10.1097/pat.0b013e3283539932 · Cited by 215

Regulation of succinate dehydrogenase and role of succinate in cancer

Dalla Pozza, E., Dando, I., Pacchiana, R., Liboi, E., Scupoli, M. T., Donadelli, M., & Palmieri, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.04.013 · Cited by 212

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background

Fishbein, L. M., & Nathanson, K. L. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.01.009 · Cited by 206

Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment

Martucci, V. L., & Pacák, K. (2014) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2014.01.001 · Cited by 212

Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention

Bausch, B., Schiavi, F., Ni, Y., Welander, J., Patócs, A., Ngeow, J. Y. Y., Wellner, U. F., Malinoc, A., Taschin, E., Barbon, G., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0223 · Cited by 200

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5

Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0268 · Cited by 200

Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma

Welander, J., Stenman, A., Juhlin, C. C., Wiseman, R. W., Bäckdahl, M., Höög, A., Larsson, C., Gimm, O., & Söderkvist, P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4375 · Cited by 177

Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics

Williams, M. D. (2017) · Head and Neck Pathology · doi:10.1007/s12105-017-0803-4 · Cited by 171

Current Approaches and Recent Developments in the Management of Head and Neck Paragangliomas

Taïeb, D., Kaliski, A., Boedeker, C. C., Martucci, V. L., Fojo, T., Adler, J. R., & Pacák, K. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1026 · Cited by 169

The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations

Asa, S. L., Ezzat, S., & Mete, Ö. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090280 · Cited by 167

Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma

Burnichon, N., Buffet, A., Parfait, B., Letouzé, É., Laurendeau, I., Loriot, C., Pasmant, É., Abermil, N., Valeyrie‐Allanore, L., Bertherat, J. Y., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds374 · Cited by 159

Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors

Wagner, A. J., Remillard, S. P., Zhang, Y., Doyle, L. A., George, S., & Hornick, J. L. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.153 · Cited by 139

The role of complex II in disease

Hoekstra, A. S., & Bayley, J. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.11.005 · Cited by 145

Recessive germline SDHA and SDHB mutations causing leukodystrophy and isolated mitochondrial complex II deficiency

Alston, C. L., Davison, J. E., Meloni, F., van der Westhuizen, F. H., He, L., Hornig‐Do, H., Peet, A. C., Gissen, P., Goffrini, P., Ferrero, I., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101146 · Cited by 135

Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma

Muth, A., Crona, J., Gimm, O., Elmgren, A., Filipsson, K., Stenmark‐Askmalm, M., Sandstedt, J., Tengvar, M., & Tham, E. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12869 · Cited by 135

Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients

Currás-Freixes, M., Inglada‐Pérez, L., Mančíková, V., Montero‐Conde, C., Letón, R., Comino‐Méndez, I., Apellániz-Ruiz, M., Sánchez, L. M. M., Sánchez-Covisa, M. A., Alcázar, V., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103218 · Cited by 129

Pheochromocytoma and paraganglioma syndromes: genetics and management update

Lefebvre, M., & Foulkes, W. D. (2013) · Current Oncology · doi:10.3747/co.21.1579 · Cited by 125

Epithelial to Mesenchymal Transition Is Activated in Metastatic Pheochromocytomas and Paragangliomas Caused by SDHB Gene Mutations

Loriot, C., Burnichon, N., Gadessaud, N., Vescovo, L., Amar, L., Libé, R., Bertherat, J. Y., Plouin, P., Jeunemaı̂tre, X., Gimenez‐Roqueplo, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3437 · Cited by 132

Alterations of metabolic genes and metabolites in cancer

Oermann, E. K., Wu, J., Guan, K., & Xiong, Y. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.013 · Cited by 125

Loss of SDHA Expression Identifies SDHA Mutations in Succinate Dehydrogenase–deficient Gastrointestinal Stromal Tumors

Dwight, T., Benn, D. E., Clarkson, A., Vilain, R. E., Lipton, L. R., Robinson, B. G., Clifton-Bligh, R. J., & Gill, A. J. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182671155 · Cited by 118

Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas

Welander, J., Larsson, C., Bäckdahl, M., Hareni, N., Sivlér, T., Brauckhoff, M., Söderkvist, P., & Gimm, O. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds402 · Cited by 112

Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era

Pillai, S., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.01.022 · Cited by 113

Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification

Eisenhofer, G., Tischler, A. S., & de Krijger, R. R. (2011) · Endocrine Pathology · doi:10.1007/s12022-011-9188-1 · Cited by 111

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers

Williamson, S. R., Gill, A. J., Argani, P., Chen, Y., Egevad, L., Kristiansen, G., Grignon, D. J., & Hes, O. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001476 · Cited by 112

Toward an improved definition of the genetic and tumor spectrum associated with SDH germ-line mutations

Evenepoel, L., Papathomas, T. G., Krol, N. M. G., Korpershoek, E., de Krijger, R. R., Persu, A., & Dinjens, W. N. M. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.162 · Cited by 107

GENETICS IN ENDOCRINOLOGY: The genetics of phaeochromocytoma: using clinical features to guide genetic testing

Jafri, M., & Maher, E. R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0497 · Cited by 107

Reactive oxygen species are generated by the respiratory complex II – evidence for lack of contribution of the reverse electron flow in complex I

Moreno‐Sánchez, R., Hernández‐Esquivel, L., Rivero‐Segura, N. A., Marín‐Hernández, A., Neuzil, J., Ralph, S. J., & Rodríguez‐Enríquez, S. (2013) · The FEBS Journal · doi:10.1111/febs.12086 · Cited by 100

SDHA mutations causing a multisystem mitochondrial disease: novel mutations and genetic overlap with hereditary tumors

Renkema, G. H., Wortmann, S. B., Smeets, R., Venselaar, H., Antoine, M., Visser, G., Ben‐Omran, T., van den Heuvel, L. P., Timmers, H. J. L. M., Smeitink, J. A. M., et al. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.80 · Cited by 97

5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer

Kroeze, L. I., van der Reijden, B. A., & Jansen, J. H. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.01.001 · Cited by 97

Syndromic gastrointestinal stromal tumors

Ricci, R. (2016) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-016-0055-4 · Cited by 95

Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine

Kimura, N., Takekoshi, K., & Naruse, M. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090242 · Cited by 95

Pheochromocytoma – update on disease management

Därr, R., Lenders, J. W. M., Hofbauer, L. C., Naumann, B., Bornstein, S. R., & Eisenhofer, G. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812437356 · Cited by 91

Genetics of hereditary head and neck paragangliomas

Boedeker, C. C., Hensen, E. F., Neumann, H. P. H., Maier, W., van Nederveen, F. H., Suarez, C. M., Kunst, H. P. M., Rodrigo, J. P., Takes, R. P., Pellitteri, P. K., et al. (2013) · Head & Neck · doi:10.1002/hed.23436 · Cited by 88

Rare insights into cancer biology

Adam, J., Yang, M., Soga, T., & Pollard, P. J. (2013) · Oncogene · doi:10.1038/onc.2013.222 · Cited by 90

Modern Nuclear Imaging for Paragangliomas: Beyond SPECT

Taïeb, D., Neumann, H. P. H., Rubello, D., AL-NAHHAS, A. M., Guillet, B. A., & Hindié, E. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.098152 · Cited by 88

An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST)

Nannini, M., Biasco, G., Astolfi, A., & Pantaleo, M. A. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101695 · Cited by 85

SDHA mutations in adult and pediatric wild-type gastrointestinal stromal tumors

Oudijk, L., Gaal, J., Korpershoek, E., van Nederveen, F. H., Kelly, L., Schiavon, G., Verweij, J., Mathijssen, R. H. J., den Bakker, M. A., Oldenburg, R. A., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.186 · Cited by 85

Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Eisenhofer, G., Klink, B., Richter, S., Lenders, J. W. M., & Robledo, M. (2017) · Europe PMC (PubMed Central) · Cited by 84

Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma

Galan, S., & Kann, P. H. (2012) · Clinical Endocrinology · doi:10.1111/cen.12071 · Cited by 83

Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study

van der Tuin, K., Mensenkamp, A. R., Tops, C. M. J., Corssmit, E. P. M., Dinjens, W. N. M., van der Horst‐Schrivers, A. N. A., Jansen, J. C., de Jong, M. M., Kunst, H. P. M., Küsters, B., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01762 · Cited by 83

Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma

Aim, L. B., Pigny, P., Castro‐Vega, L. J., Buffet, A., Amar, L., Bertherat, J. Y., Drui, D., Guilhem, I., Baudin, É., Lussey‐Lepoutre, C., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105714 · Cited by 83

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Paragangliomas

Williams, M. D., & Tischler, A. S. (2017) · Head and Neck Pathology · doi:10.1007/s12105-017-0786-1 · Cited by 83

Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum

Niemeijer, N. D., Papathomas, T. G., Korpershoek, E., de Krijger, R. R., Oudijk, L., Morreau, H., Bayley, J., Hes, F. J., Jansen, J. C., Dinjens, W. N. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2689 · Cited by 81

Paragangliomas/Pheochromocytomas: Clinically Oriented Genetic Testing

Martins, R., & Bugalho, M. J. (2014) · International Journal of Endocrinology · doi:10.1155/2014/794187 · Cited by 82

Clinical implications of the oncometabolite succinate in SDHx ‐mutation carriers

Eijkelenkamp, K., Osinga, T. E., Links, T. P., & van der Horst‐Schrivers, A. N. A. (2019) · Clinical Genetics · doi:10.1111/cge.13553 · Cited by 78

PheoSeq

Currás-Freixes, M., Piñeiro-Yáñez, E., Montero‐Conde, C., Apellániz-Ruiz, M., Calsina, B., Mančíková, V., Remacha, L., Richter, S., Ercolino, T., Rogowski-Lehmann, N., et al. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.04.009 · Cited by 78

Succinate Dehydrogenase-deficient Tumors

Barletta, J. A., & Hornick, J. L. (2012) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31825c6bc6 · Cited by 75

Evaluation of SDHB , SDHD and VHL gene susceptibility testing in the assessment of individuals with non‐syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma

Jafri, M., Whitworth, J., Rattenberry, E., Vialard, L., Kilby, G., Kumar, A., Izatt, L., Lalloo, F. I., Brennan, P., Cook, J. A., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12074 · Cited by 73

Precision Medicine: An Update on Genotype/Biochemical Phenotype Relationships in Pheochromocytoma/Paraganglioma Patients

Gupta, G., & Pacák, K. (2017) · Endocrine Practice · doi:10.4158/ep161718.ra · Cited by 77

A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes

Scollon, S., Anglin, A. K., Thomas, M. H., Turner, J. T., & Schneider, K. W. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0077-8 · Cited by 72

Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes

Nosé, V., Gill, A. J., Cameselle‐Teijeiro, J., Perren, A. A., & Erickson, L. A. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09705-5 · Cited by 70

The Genetics of Neuroendocrine Tumors

Öberg, K. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.11.005 · Cited by 68

Pheochromocytoma and Paraganglioma

Pacák, K., & Wimalawansa, S. J. (2015) · Endocrine Practice · doi:10.4158/ep14481.ra · Cited by 71

Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications

Impériale, A., Moussallieh, F., Roche, P., Battini, S., Çiçek, A. E., Sebag, F. A., Brunaud, L., Barlier, A., Elbayed, K., Loundou, A., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2014.10.010 · Cited by 69

In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDH x Mutations in Paraganglioma

Lussey‐Lepoutre, C., Bellucci, A., Morin, A., Buffet, A., Amar, L., Janin, M., Ottolenghi, C., Zinzindohoué, F., Autret, G., Burnichon, N., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1576 · Cited by 76

Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

Calsina, B., Currás-Freixes, M., Buffet, A., Pons, T., Contreras, L., Letón, R., Comino‐Méndez, I., Remacha, L., Calatayud, M., Obispo, B., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0068-7 · Cited by 69

A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling

Yakirevich, E., Ali, S. M., Mega, A. E., McMahon, C., Brodsky, A. S., Ross, J. S., Allen, J. M., Elvin, J. A., Safran, H. P., & Resnick, M. B. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000403 · Cited by 68

15 YEARS OF PARAGANGLIOMA: Pathology of pheochromocytoma and paraganglioma

Tischler, A. S., & de Krijger, R. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0261 · Cited by 66

Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry

Juhlin, C. C. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09675-0 · Cited by 69

Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer

Zecchini, V. R., Madhu, B., Russell, R., Pértega‐Gomes, N., Warren, A. Y., Gaude, E., Borlido, J., Stark, R., Zecchini, H. I., Rao, R. B., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201386874 · Cited by 65

GEP- NETS UPDATE: Genetics of neuroendocrine tumors

Crona, J., & Skogseid, B. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0972 · Cited by 71

Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas

Chan, S. H., Lim, W. K., Ishak, N. D. B., Li, S.-T., Goh, W. L., Tan, G. S., Lim, K. H., Teo, M. C. C., Young, C. C., Malik, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10333-x · Cited by 65

Bayesian approach to determining penetrance of pathogenic SDH variants

Benn, D. E., Zhu, Y., Andrews, K. A., Wilding, M., Duncan, E. L., Dwight, T., Tothill, R. W., Burgess, J. R., Crook, A., Gill, A. J., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105427 · Cited by 68

SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors

Italiano, A., Chen, C.-L., Sung, Y., Singer, S., DeMatteo, R. P., LaQuaglia, M. P., Besmer, P., Socci, N. D., & Antonescu, C. R. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-408 · Cited by 65

Protocol for the Examination of Specimens From Patients With Pheochromocytomas and Extra-Adrenal Paragangliomas

Mete, Ö., Tischler, A. S., de Krijger, R. R., McNicol, A. M., Eisenhofer, G., Pacák, K., Ezzat, S., & Asa, S. L. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0551-oa · Cited by 61

Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors

Belinsky, M. G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00117 · Cited by 61

Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma

Jha, A., de Luna, K. S., Balili, C. A., Millo, C., Paraiso, C. A., Ling, A. L., Gonzales, M. K., Viana, B., Alrezk, R., Adams, K. T., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00053 · Cited by 61

A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma

MacFarlane, J., Seong, K. C., Bisambar, C., Madhu, B., Allinson, K. S. J., Marker, A. J., Warren, A. Y., Park, S., Giger, O., Challis, B., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14289 · Cited by 64

Genetic bases of pheochromocytoma and paraganglioma

Cascón, A., Calsina, B., Monteagudo, M., Mellid, S., Díaz‐Talavera, A., Currás-Freixes, M., & Robledo, M. (2022) · Journal of Molecular Endocrinology · doi:10.1530/jme-22-0167 · Cited by 65

The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes

Udager, A. M., Magers, M. J., Goerke, D. M., Vinco, M., Siddiqui, J., Cao, X., Lucas, D. R., Myers, J. L., Chinnaiyan, A. M., McHugh, J. B., et al. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.10.013 · Cited by 58

The genetic basis of isolated mitochondrial complex II deficiency

Fullerton, M., McFarland, R., Taylor, R. W., & Alston, C. L. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.09.009 · Cited by 57

Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients

Fuchs, T. L., Maclean, F. M., Turchini, J., Vargas, A. C., Bhattarai, S., Agaimy, A., Hartmann, A., Kao, C., Ellis, C. L., Bonert, M., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00998-1 · Cited by 55

SDHD Immunohistochemistry: A New Tool to ValidateSDHxMutations in Pheochromocytoma/Paraganglioma

Menara, M., Oudijk, L., Badoual, C., Bertherat, J. Y., Lussey‐Lepoutre, C., Amar, L., Iturrioz, X., Sibony, M., Zinzindohoué, F., de Krijger, R. R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1870 · Cited by 55

Diagnosis and management of pheochromocytoma

Hodin, R. A., Lubitz, C. C., Phitayakorn, R., & Stephen, A. E. (2014) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2013.12.001 · Cited by 55

Precision medicine in pheochromocytoma and paraganglioma: current and future concepts

Björklund, P., Pacák, K., & Crona, J. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12507 · Cited by 59

Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency

Pitsava, G., Settas, N., Faucz, F. R., & Stratakis, C. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.680609 · Cited by 58

An update on the genetics of pheochromocytoma

Karásek, D., Shah, U. A., Fryšák, Z., Stratakis, C. A., & Pacák, K. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2012.20 · Cited by 54

Structural basis for malfunction in complex II

Iverson, T. M., Maklashina, E., & Cecchini, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.408419 · Cited by 53

Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics

Her, Y. F., & Maher, L. J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/296167 · Cited by 53

Usefulness of Negative and Weak–Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas

Castelblanco, E., Santacana, M., Valls, J., Cubas, A. D., Cascón, A., Robledo, M., & Matías‐Guiu, X. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9269-4 · Cited by 51

Molecular and Therapeutic Advances in the Diagnosis and Management of Malignant Pheochromocytomas and Paragangliomas

Lowery, A., Walsh, S. M., McDermott, E. W. M., & Prichard, R. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0410 · Cited by 53

Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain

García-Heredia, J. M., & Carnero, A. (2015) · Oncotarget · doi:10.18632/oncotarget.6057 · Cited by 53

SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity

Casey, R. T., Ascher, D. B., Rattenberry, E., Izatt, L., Andrews, K. A., Simpson, H., Challis, B. G., Park, S., Bulusu, V. R., Lalloo, F. I., et al. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.279 · Cited by 52

Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin

Koopman, K., Gaal, J., & de Krijger, R. R. (2019) · Cancers · doi:10.3390/cancers11081070 · Cited by 55

Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations

Pinato, D. J., Ramachandran, R., Toussi, S. T. K., Vergine, M., Ngo, N., Sharma, R., Lloyd, T., Meeran, K. M., Palazzo, F. F., Martin, N., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.538 · Cited by 55

Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline SDHx Gene Mutation

Santi, R., Rapizzi, E., Canu, L., Ercolino, T., Baroni, G., Fucci, R., COSTA, G., Mannelli, M., & Nesi, G. (2017) · Anticancer Research · doi:10.21873/anticanres.11381 · Cited by 35

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F. B. M., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 554

SDHD Immunohistochemistry: A New Tool to ValidateSDHxMutations in Pheochromocytoma/Paraganglioma

Menara, M., Oudijk, L., Badoual, C., Bertherat, J. Y., Lussey‐Lepoutre, C., Amar, L., Iturrioz, X., Sibony, M., Zinzindohoué, F., de Krijger, R. R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1870 · Cited by 55

Usefulness of Negative and Weak–Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas

Castelblanco, E., Santacana, M., Valls, J., Cubas, A. D., Cascón, A., Robledo, M., & Matías‐Guiu, X. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9269-4 · Cited by 51

Prevalence of succinate dehydrogenase deficiency in paragangliomas and phaeochromocytomas at a tertiary hospital in Cape Town: a retrospective review

Bruce‐Brand, C., & van Wyk, A. C. (2020) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2020.1838161 · Cited by 5